Clinical Trials Logo

Filter by:
NCT ID: NCT06082609 Enrolling by invitation - Clinical trials for Dental Prosthesis Complication

Functional Relining Versus Digital Altered Cast Using Digitally Fabricated Distal Extension Frameworks

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

This clinical study will be done to compare between functional relining and digital altered cast of selective pressure impression techniques for constructing mandibular distal extension removable partial dentures using digitally fabricated frameworks by measuring the abutment alveolar bone height changes.

NCT ID: NCT05923359 Enrolling by invitation - Atrial Fibrillation Clinical Trials

Realtime Diagnosis From Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation With Long Follow-Up (REGAL)

Start date: April 10, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation.

NCT ID: NCT06186219 Enrolling by invitation - Tophaceous Gout Clinical Trials

Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout

Start date: April 10, 2024
Phase: Phase 1
Study type: Interventional

This safety and feasibility, open-label study of up to 9 subjects will examine a group of subjects with poorly controlled tophaceous gout (intolerant to or ineffective oral urate lowering agents and loss of prior Pegloticase response) pre-treated with Rituximab to recapture response to Methotrexate-Pegloticase.

NCT ID: NCT06205771 Enrolling by invitation - Preeclampsia Clinical Trials

The Role and Mechanism of GPER-Hippo-CBS/H2S Pathway in Preeclampsia

Start date: April 10, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about in health conditions. The main questions it aims to answer are: - The pathological significance of GPER in uterine artery dilation in preeclampsia - The Mechanism of GPER Hippo Pathway Regulating CBS/H2S in Human Uterine Artery Smooth Muscle Cells (hUASMC) This project intends to use GPER interfering RNA, YAP1 interfering RNA, in vivo perfusion experiments of human uterine artery tissue, and single cell patch clamp technology to study hypotheses under physiological/pathological pregnancy conditions at the tissue, cellular, and molecular levels, revealing a novel signal transduction pathway of estrogen stimulating vasodilation, providing new ideas for studying the mechanism of uterine artery blood flow regulation. This research result will provide new targets for intervention and treatment of diseases such as fetal intrauterine growth retardation and preeclampsia.

NCT ID: NCT06374004 Enrolling by invitation - Clinical trials for Subacromial Pain Syndrome

The Effect of Thoracic Mobilization in Individuals With Subacromial Pain Syndrome

Start date: April 10, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of six-week thoracic mobilization on pain intensity, muscle tone, functional and muscle activation in individuals with subacromial pain syndrome.

NCT ID: NCT03643991 Enrolling by invitation - Dementia Clinical Trials

Decreasing Agitation in Patients With Dementia Through the Use of Weighted Blankets

Start date: April 11, 2018
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine whether the use of weighted blankets help reduce behavioral and psychological symptoms, including agitation in people with dementia.

NCT ID: NCT04163354 Enrolling by invitation - Child Clinical Trials

Glass Ionomer Sealant Versus Fluoride Varnish on Occlusal Caries Prevention

Start date: April 11, 2018
Phase: N/A
Study type: Interventional

The current study compares the efficacy of glass ionomer fissure sealant versus topical application of 5% sodium fluoride varnish in prevention of occlusal caries among preschool children.

NCT ID: NCT04571749 Enrolling by invitation - Communication Clinical Trials

Handoffs and Transitions in Critical Care - Understanding Scalability

HATRICC-US
Start date: April 11, 2021
Phase: N/A
Study type: Interventional

The investigators will leverage implementation science and engineering to adapt, implement, and rigorously evaluate tailored postoperative handoff protocols and implementation strategies. In doing so, the investigators will develop a vital understanding of the factors needed for successful and sustained use of evidence-based interventions in acute care. This knowledge will inform approaches to bridge the evidence-to-practice gap that prevents effective interventions from realizing the promise of improved patient outcomes in acute care settings.

NCT ID: NCT05263362 Enrolling by invitation - Breast Cancer Clinical Trials

An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)

STARLINGS
Start date: April 11, 2022
Phase:
Study type: Observational

To assess the role of different combinations of (oncoplastic) surgery and radiotherapy techniques as risk factors for moderate to severe fibrosis and for moderate to poor cosmetic outcome.

NCT ID: NCT05312060 Enrolling by invitation - Edema Leg Clinical Trials

Pneumatic Compression Versus Anti-thromboembolic Exercises for Patients Undergoing Total Hip Arthroplasty

Start date: April 11, 2022
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial, with two parallel arms. The open-label study will be conducted in accordance with the helsinky statement and good clinical practice standards. The main objective is to compare the reduction of postoperative edema following Total Hip Arthroplasty (THA) between patients undergoing postoperative treatment with pneumatic compression (PC, experimental group) and patients undergoing postoperative treatment with antithromboembolic exercises. (AE, control group). We also aim to compare the pre-post treatment variations of joint function measurements (joint excursion), referred pain and functional capabilities. 48 patients will meet the criteria listed below will be recruited. Inclusion criteria: - total hip arthroplasty under election regime - aged between 50 and 80 at the time of recruitment, both sexes. Exclusion criteria: - obesity (BMI> 30); - other orthopedic or neurological pathologies that modify walking ability; - pathologies that modify balance (neurological and / or vestibular); - contraindications to the use of the medical equipment used in the study; - inability to understand and sign informed consent. Participants will be assigned, through a block randomization, to one of the two study groups: experimental group will undergo pneumatic compression treatment (PC), control group will perform antithromboembolic exercises (AE). For both, the treatment will last 10 working days, starting from the first post surgery day (T0). The PC will undergo two daily 30-minute sessions of sequential pneumatic compression (I-Press®, I-Tech Medical Division, Martellago, Italy) while AE will perform two supervised antithromboembolic exercises sessions daily lasting 30 minutes. All participants will carry out the antithrombotic prophylaxis in use at the department of orthopedics: drug therapy, graduated compression stocking and indirect electrostimulation (T-One Rehab®, I-Tech Medical Division, Martellago, Italy). Assessments of edema, joint range of motion, pain and functional capabilities will be made at T0 and at the end of the treatment (T1).